AhmadS,HughesMA,YehLA,etal.Potentialrepurposingofknowndrugsaspotentbacterialβ-glucuronidaseinhibitors.JBiomolScreen.2012Aug;17(7):957-65.PMID:22535688.
YangG,ZhouMH,RenZ,etal.AmoxapineinhibitsdelayedoutwardrectifierK(+)currentsincerebellargranulecellsviadopaminereceptorandproteinkinaseAactivation.CellPhysiolBiochem.2011;28(1):163-74.PMID:21865859.
ObersS,StaudacherI,FickerE,etal.MultiplemechanismsofhERGliABIlity:K+currentinhibition,disruptionofproteintrafficking,andapoptosisinducedbyamoxapine.NaunynSchmiedebergsArchPharmacol.2010May;381(5):385-400.PMID:20229012.
ChaudhryIB,HusainN,KhanS,etal.Amoxapineasanantipsychotic:comparativestudyversushaloperidol.JClinPsychopharmacol.2007Dec;27(6):575-81.PMID:18004123.
TakebayashiM,KagayaA,InagakiM,etal.Effectsofantidepressantsongamma-aminobutyricacid-andN-methyl-D-aspartate-inducedintracellularCa(2+)concentrationincreasesinprimaryculturedratcorticalneurons.NeuropsychoBIOLOGy.2000;42(3):120-6.PMID:11015029.
RothBL,CraigoSC,ChoudharyMS,etal.Bindingoftypicalandatypicalantipsychoticagentsto5-hydroxytryptamine-6and5-hydroxytryptamine-7receptors.JPharmacolExpTher.1994Mar;268(3):1403-10.PMID:7908055.
GozlanH,Saddiki-TrakiF,MerahiN,etal.Preclinicalpharmacologyofamoxapineandamitriptyline.Implicationsofserotoninergicandopiodergicsystemsintheircentraleffectinrats.Encephale.1991Dec;17SpecNo3:415-22.PMID:1666997.
HamonM,GozlanH,BourgoinS,etal.OpioidreceptorsandneuropeptidesintheCNSinratstreatedchronicallywithamoxapineoramitriptyline.Neuropharmacology.1987Jun;26(6):531-9.PMID:3037421.